Could CBD help treat smokeless tobacco addiction?

2y
1m read
Summary

A 2018 study published in the journal Addiction also found that CBD holds promise as a treatment for tobacco addiction. CV Sciences has patented a proprietary CBD and nicotine formulation for treating smokeless tobacco addiction. It “further extends our potential product development opportunities to commercialize the world’s first and only U.S. Federal Drug Administration-approved treatment for smokeless tobacco addiction to address a huge unmet medical need and global health issue,” he added. Study: Cannabidiol shows promise as treatment for tobacco addiction Study: CBD may help block pain-signalling pathways Four things about CBD cigarettes you should know The study “further validates our years of investment and hard work,” said Joseph Dowling, CEO of C.V. Sciences. “This study marked a key milestone in C.V. Sciences’ smokeless tobacco addiction treatment R&D (research and development) efforts,” Dowling said in a news release. New research from C.V. Sciences, Inc., a hemp-derived CBD company, in collaboration with the University of California, San Diego, has found further evidence that CBD could reduce nicotine dependence and withdrawal symptoms.

Article Preview

New research from C.V. Sciences, Inc., a hemp-derived CBD company, in collaboration with the University of California, San Diego, has found further evidence that CBD could reduce nicotine dependence and withdrawal symptoms.

Using animal models, the preclinical study found that CBD prevented nicotine-dependent rats from exhibiting withdrawal symptoms such as somatic signs, hyperalgesia and weight gain, during short and long-term nicotine restriction.

Study: Cannabidiol shows...

Read the full article @ The Growth Op